Technology for natural anti-asthmatic drug transferred to Hankuk Shinyak.

Korea Bio Engineering Research Institute (KBERI) has developed an anti-asthmatic drug from the extracts of Yulan magnolid, a natural herb, under the government (MOST) financial subsidy (1 billion won) as one of the G7 projects, and recently made an exclusive distribution agreement with Hankuk Shinyak, a herbal pharmaceutical manufacturer on Feb. 20.

KBERI will receive 300 million won of adv...